Search

everythinglearnresearchcommunity

for

Search:↓

Dupilumab for skin problems might reactivate hair loss in some patients.

The conclusion is that endocrinology significantly impacts medicine with various common medications used for treatment.

Tadalafil may reduce the risk of major heart events and blood clots in men with urinary symptoms.

The document suggests a personalized treatment plan for alopecia areata based on the patient's age and hair loss severity, using a range of therapies ranked by effectiveness and safety.

Taking 5α-reductase inhibitors does not significantly increase the risk of breast cancer in men.

The conclusion is that more hair loss (androgenetic alopecia) is linked to larger prostate size, suggesting hair loss could be an early sign of benign prostatic hyperplasia.

A girl with Crohn's disease developed hair loss due to her increased medication, a rare side effect seen in some children.

Hydroxychloroquine showed some potential, but overall, the three drugs had limited success in treating lupus in dogs.

Women experience more side effects and have worse blood pressure control from hypertension treatments than men, despite using different medications.

We need to learn more about 5α-reductases and neuroactive steroids to safely make drugs targeting these enzymes.

The document concludes that Hidradenitis suppurativa is often underdiagnosed, lacks definitive treatment, and requires better awareness and management strategies.

Enzymes called 5α-reductases have many body functions and need more research to safely use inhibitors.

A patient with PPP had rare skin reactions to adalimumab, which improved after stopping smoking and continuing acitretin.

Finasteride helps hair growth and prostate issues but may cause sexual side effects and increase tumor risk.

Stopping tamsulosin one month before cataract surgery reduces eye surgery complications in rats.

Finasteride may increase erectile dysfunction risk in patients with benign prostatic hyperplasia.

Combination therapy of doxazosin and finasteride safely and effectively reduces benign prostatic hyperplasia progression risk.

Finasteride effectively inhibits 5α reductase, while plant extracts like Permixon and Bazoton don't show significant results.

Some plant-based treatments can help with benign prostatic hyperplasia symptoms, but more research is needed to confirm their safety and effectiveness.

Finasteride worsens erectile dysfunction and lowers testosterone in men with enlarged prostates, unlike tamsulosin.

Quick, selective detection of tadalafil and finasteride in human plasma developed.

Dutasteride and finasteride have similar risk for osteoporosis and fractures in older men.

Finasteride before TURP reduces blood loss and slightly improves early postoperative quality of life.

Photodynamic therapy may not work for erythroplasia of Queyrat and could lead to invasive squamous cell carcinoma.

Hormonal changes and psychological issues can cause sexual dysfunction in postmenopausal women. Behavioral therapy is recommended first, with hormone replacement helping some symptoms but not libido. Testosterone can improve libido, but its effects on overall sexual function are unclear. Emotional and relationship issues should be addressed before using medication, and the benefits and risks of testosterone supplementation should be considered.

Certain medications can reduce sexual desire and function, especially in women.

Finasteride before TURP reduces blood loss and improves early postoperative quality of life.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Minoxidil treats high blood pressure and side effects can be managed.

Finasteride use doesn't cause sexual dysfunction in men with hair loss.